A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants
Clinical trial NCT06589726 · COMPLETED
Trial details
- NCT number
- NCT06589726
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2024-12-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.